DMT shows positive results in trials for the treatment and prevention of Alzheimer’s disease

By |2024-05-09T03:04:58+01:009 May 2024|

A study published in the journal BioMed Central has shown how the psychedelic N, N-Dimethyltryptamine (DMT) could be used as a medicine to prevent the onset of the neurodegenerative condition Alzheimer’s disease (AD).  According to the NHS, Alzheimer’s disease is the most common cause of dementia [...]

Comments Off on DMT shows positive results in trials for the treatment and prevention of Alzheimer’s disease

UK CBD update: FSA issues first positive safety assessments in Novel Food process

By |2024-05-09T03:02:23+01:009 May 2024|

The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation process. Chanelle McCoy’s subsidiary, Pureis, became the first company in the UK to receive a positive risk assessment for a synthetic CBD [...]

Comments Off on UK CBD update: FSA issues first positive safety assessments in Novel Food process